[1] |
Park KW, Kim SH, Choi SH, et al. Differentiation of nonneoplastic and neoplastic gallbladder polyps 1 cm or bigger with multi-detector row computed tomography[J]. J Comput Assist Tomogr, 2010, 34(1):135-139.
|
[2] |
McCain RS, Diamond A, Jones C, et al. Current practices and future prospects for the management of gallbladder polyps: a topical review[J]. World J Gastroenterol, 2018, 24(26):2844-2852.
|
[3] |
Lee YJ, Park KS, Cho KB, et al. Shifting prevalence of gallbladder polyps in Korea[J]. J Korean Med Sci, 2014, 29(9):1247-1252.
|
[4] |
Mao YS, Mai YF, Li FJ, et al. Prevalence and risk factors of gallbladder polypoid lesions in Chinese petrochemical employees[J]. World J Gastroenterol, 2013, 19(27):4393-4399.
|
[5] |
Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps: joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery-European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE)[J]. Eur Radiol, 2017, 27(9): 3856-3866.
|
[6] |
Lee SR, Kim HO, Shin JH. Reasonable cholecystectomy of gallbladder polyp-10 years of experience[J]. Asian J Surg, 2019, 42(1):332-337.
|
[7] |
Hu MT, Wang JH, Yu Y, et al. Tumor suppressor LKB1 inhibits the progression of gallbladder carcinoma and predicts the prognosis of patients with this malignancy[J]. Int J Oncol, 2018, 53(3):1215-1226.
|
[8] |
Bubnova MG, Kukharchuk VV. Recommendations of the European Society of Cardiology and the European Atherosclerosis Society on cardiovascular disease prevention and management of dyslipidemias. for the diagnosis of atherosclerosis and dyslipidemia treatment (2016): basic S.G.[J]. Kardiologiia, 2017, 57(3):85-89.
|
[9] |
Christensen AH, Ishak KG. Benign tumors and pseudotumors of the gallbladder. report of 180 cases[J]. Arch Pathol, 1970, 90(5):423-432.
|
[10] |
Xu A, Zhang Y, Hu H, et al. Gallbladder polypoid-lesions: what are they and how should they be treated? a single-center experience based on 1 446 cholecystectomy patients[J]. J Gastrointest Surg, 2017, 21(11):1804-1812.
|
[11] |
Xu A, Hu H. The gallbladder polypoid-lesions conundrum: moving forward with controversy by looking back[J]. Expert Rev Gastroenterol Hepatol, 2017, 11(11):1071-1080.
|
[12] |
Prokop LD. Isotretinoin: possible component cause of inflammatory bowel disease[J]. Am J Gastroenterol, 1999, 94(9):2568.
|
[13] |
Akiyama T, Sahara H, Seto K, et al. Gallbladder cancer associated with cholesterosis[J]. J Gastroenterol, 1996, 31(3):470-474.
|
[14] |
Choi YS, Do JH, Seo SW, et al. Prevalence and risk factors of gallbladder polypoid lesions in a healthy population[J]. Yonsei Med J, 2016, 57(6):1370-1375.
|
[15] |
Yang HL, Kong L, Hou LL, et al. Analysis of risk factors for polypoid lesions of gallbladder among health examinees[J]. World J Gastroenterol, 2012, 18(23):3015-3019.
|
[16] |
赵刚,吴志勇. 胆囊癌癌前病变的新认识与处理原则[J]. 中国实用外科杂志,2011(3):198-202.
|
[17] |
Adsay NV. Neoplastic precursors of the gallbladder and extrahepatic biliary system[J]. Gastroenterol Clin North Am, 2007, 36(4):889-900, vii.
|
[18] |
Sasatomi E, Tokunaga O, Miyazaki K. Precancerous conditions of gallbladder carcinoma: overview of histopathologic characteristics and molecular genetic findings[J]. J Hepatobiliary Pancreat Surg, 2000, 7(6):556-567.
|
[19] |
伍英,熊环,何睿,等. 广州市某三级甲等医院2005年-2014年原发性胆囊癌手术患者住院情况分析[J]. 中国病案,2015,16(9):72-75.
|
[20] |
Limberg J, Ullmann TM, Gray KD, et al. Laparoscopic adrenalectomy has the same operative risk as routine laparoscopic cholecystectomy[J]. J Surg Res, 2019(241):228-234.
|